Press Releases
Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments
Boehringer Ingelheim and Eli Lilly and Company announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid-...
Industry Reports
Genzyme Financial Recovery Continues in Fourth Quarter
Genzyme Corp. reported that preliminary fourth-quarter revenue grew 23 percent to $1.15 billion from $938 million in the fourth quarter of 2009. For the...
Press Releases
Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab
Sandoz announced today that it has begun a phase II clinical trial in patients for biosimilar rituximab (Roche's Rituxan® / Mabthera), a leading monoclonal...
Clinical Trials
Patients enrolled in EU Phase III Clinical Development Progam to evaluate ATX-101 for Reduction of Submental Fat
Bayer HealthCare’s dermatology business Intendis and KYTHERA Biopharmaceuticals, Inc. announced the initiation of two European Phase III studies evaluating ATX-101, a first-in-class injectable adipolytic...
Press Releases
Whats on the horizon for pharma sales- a look to the year ahead from UCB, Sanofi-Aventis & Actelion
eyeforpharma recently interviewed: Hans Hoogkamer, Business and Science Affairs, Actelion Pharmaceuticals, Daniel Ghozzi, Managing Director CIS, UCB Pharma Russia & Rune Pilegaard Associate Director,...
Press Releases
Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse Capsules
Shire plc, the global specialty biopharmaceutical company, today announced results from a study of Vyvanse®, assessing its effect in a model for Excessive Daytime...
Press Releases
Merck Expand Study Investigating Erbitux as 1st Line Treatment in Advanced Gastric Cancer Completes Recruitment
Merck KGaA announced that recruitment has been completed for the pivotal Phase III EXPAND(a) clinical trial investigating the efficacy of Erbitux® (cetuximab) in treating...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read